SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were used in successful telesurgeries during two international medical conferences in October 2026. The demonstrations underscore the growing viability of remote robotic surgery and its potential to bridge geographic gaps in specialized care.
At the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient in Bengaluru, India, approximately 7,500 miles away. The feat highlights the SSi MantrAsana console’s ability to enable real-time remote surgery through ultra-low latency connectivity, high-definition visualization and precise instrument control. Such capabilities could allow expert surgeons to operate on patients in underserved or remote regions without travel, potentially reducing delays and improving outcomes.
Separately, at the Society of Robotic Surgery India (SRS India) Conference in New Delhi, four surgeons completed four separate robotic-assisted telesurgeries involving kidney, colorectal, pediatric urological and gynecological procedures. These varied cases demonstrate the versatility of the SSi Mantra system across multiple surgical specialties, suggesting broader applications for telesurgery beyond cardiac care.
As of Oct. 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system. This cumulative experience provides a foundation for regulatory acceptance and clinical adoption of remote robotic surgery, which could disrupt traditional models of surgical care delivery by enabling centralized expertise to be leveraged across multiple locations.
SS Innovations aims to make robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes the SSi Mantra system and SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its cost-effective surgical robotic solutions. For more information, visit ssinnovations.com or LinkedIn. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
The demonstrations also come as SS Innovations International (NASDAQ: SSII) seeks to differentiate itself in the competitive surgical robotics market. By proving that complex procedures can be performed reliably over vast distances, the company may open new markets where access to specialized surgeons is limited. The successful telesurgeries could also accelerate conversations among regulators and healthcare providers about standards for remote surgery, including liability, credentialing and infrastructure requirements.
For investors, the announcements signal progress in validating the SSi Mantra platform’s telesurgery capabilities, which could drive adoption and revenue growth. The company’s focus on affordability positions it to compete in cost-sensitive markets, particularly in emerging economies where robotic surgery has been historically underutilized. As healthcare systems worldwide grapple with surgeon shortages and geographic disparities in care, technologies that enable remote surgery could become increasingly important.
To view the full press release, visit https://ibn.fm/Ujtlm. TechMediaWire, a specialized communications platform focused on technology companies, published the announcement as part of its corporate communications solutions. For details on the platform’s terms, see https://www.TechMediaWire.com/Disclaimer.
